Handbook of Clinical medicine

pneumocystis, and CMV prophylaxis has a role. __OOHHCCMM__1100ee..iinnddbb 335522 0022//0055//22001177 1199::0077 ygolotameaH MASCC score 353 The Multinational Association for Supportive Care in Cancer (MASCC) assess- ment tool can be used to predict the risk of serious complications in febrile neu- tropaenia, and can inform management decisions: if the total score is 21, risk of septic complications is low and admission may be avoided. • Solid tumour or lymphoma with no previous fungal infection 4 • Outpatient status at onset of fever (not needing admission) 3 • Age <60yrs 2 • Burden of illness: • Mild (or no) symptoms 5 • Moderate symptoms 3 • Severe symptoms 0 • No hypotension (systolic BP >90mmHg) 5 • No COPD 4 • No dehydration 3 Note the subjectivity of the ‘burden of illness’ and the omission of potentially vital variables such as CRP (which, should it fail to fall after starting antibiotics predicts treatment failure). As with all other scores, the MASCC score should therefore be interpreted within the context of the individual clinical picture. Fig 8.44 The appearance of disseminated intravascular coagulation (DIC) on the sole. Courtesy of the Crookston Collection. __OOHHCCMM__1100ee..iinnddbb 335533 0022//0055//22001177 1199::0077 ygolotameaH 354 Acute lymphoblastic leukaemia (ALL) A
